APA সাইটেশন

Ferns, D. M., Kema, I. P., Buist, M. R., Nijman, H. W., Kenter, G. G., & Jordanova, E. S. (2015). Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival. Oncoimmunology.

শিকাগো স্টাইলে সাইটেশন

Ferns, Debbie M., Ido P. Kema, Marrije R. Buist, Hans W. Nijman, Gemma G. Kenter, এবং Ekaterina S. Jordanova. "Indoleamine-2,3-dioxygenase (IDO) Metabolic Activity Is Detrimental for Cervical Cancer Patient Survival." Oncoimmunology 2015.

এমএলএ সাইটেশন

Ferns, Debbie M., et al. "Indoleamine-2,3-dioxygenase (IDO) Metabolic Activity Is Detrimental for Cervical Cancer Patient Survival." Oncoimmunology 2015.